These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 16895517

  • 1. Increasing fungal infections in the intensive care unit.
    De Pauw BE.
    Surg Infect (Larchmt); 2006; 7 Suppl 2():S93-6. PubMed ID: 16895517
    [Abstract] [Full Text] [Related]

  • 2. New developments in the diagnosis and management of invasive fungal infections.
    De Marie S.
    Haematologica; 2000 Jan; 85(1):88-93. PubMed ID: 10629598
    [Abstract] [Full Text] [Related]

  • 3. The changing epidemiology of invasive fungal infections: new threats.
    Maschmeyer G.
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():3-6. PubMed ID: 16707250
    [Abstract] [Full Text] [Related]

  • 4. A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999.
    Lortholary O, Charlemagne A, Bastides F, Chevalier P, Datry A, Gonzalves MF, Michel G, Tilleul P, Veber B, Herbrecht R.
    J Antimicrob Chemother; 2004 Aug; 54(2):456-64. PubMed ID: 15231769
    [Abstract] [Full Text] [Related]

  • 5. Clinical efficacy of new antifungal agents.
    Kauffman CA.
    Curr Opin Microbiol; 2006 Oct; 9(5):483-8. PubMed ID: 16904366
    [Abstract] [Full Text] [Related]

  • 6. Antifungal therapy in invasive fungal infections.
    Chen SC, Playford EG, Sorrell TC.
    Curr Opin Pharmacol; 2010 Oct; 10(5):522-30. PubMed ID: 20598943
    [Abstract] [Full Text] [Related]

  • 7. Antifungal treatment strategies in high risk patients.
    Rüping MJ, Vehreschild JJ, Cornely OA.
    Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
    [Abstract] [Full Text] [Related]

  • 8. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
    Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O.
    Clin Infect Dis; 2008 Jan 15; 46(2):201-11. PubMed ID: 18171251
    [Abstract] [Full Text] [Related]

  • 9. Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit.
    Devlin RK.
    Adv Neonatal Care; 2006 Apr 15; 6(2):68-77; quiz 78-9. PubMed ID: 16618476
    [Abstract] [Full Text] [Related]

  • 10. High-dose fluconazole therapy in Intensive Care Unit.
    De Bellis P, Bonfiglio M, Gerbi G, Bacigalupo P, Buscaglia G, Guido P, Massobrio B.
    Minerva Anestesiol; 2003 Mar 15; 69(3):145-52, 153-57. PubMed ID: 12792583
    [Abstract] [Full Text] [Related]

  • 11. Recent advances in antifungal chemotherapy.
    Petrikkos G, Skiada A.
    Int J Antimicrob Agents; 2007 Aug 15; 30(2):108-17. PubMed ID: 17524625
    [Abstract] [Full Text] [Related]

  • 12. [Intra-abdominal mycoses].
    Boos C, Kujath P, Bruch HP.
    Mycoses; 2005 Aug 15; 48 Suppl 1():22-6. PubMed ID: 15826283
    [Abstract] [Full Text] [Related]

  • 13. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M, Aloisi T, Irrera G, Bonini A, Picardi M, Caramatti C, Invernizzi R, Mattei D, Melillo L, de Waure C, Reddiconto G, Fianchi L, Valentini CG, Girmenia C, Leone G, Aversa F.
    Clin Infect Dis; 2007 Nov 01; 45(9):1161-70. PubMed ID: 17918077
    [Abstract] [Full Text] [Related]

  • 14. [Diagnostics and therapy for invasive fungal infections in an intensive care unit].
    Koch S, Haefner H, Huenger F, Haase G, Wildberger J, Lemmen SW.
    Anaesthesist; 2005 Oct 01; 54(10):1047-64; quiz 1065-6. PubMed ID: 16211405
    [Abstract] [Full Text] [Related]

  • 15. Surgical critical care: fungal infections in surgical patients.
    Lipsett PA.
    Crit Care Med; 2006 Sep 01; 34(9 Suppl):S215-24. PubMed ID: 16917426
    [Abstract] [Full Text] [Related]

  • 16. Changing patterns and trends in systemic fungal infections.
    Richardson MD.
    J Antimicrob Chemother; 2005 Sep 01; 56 Suppl 1():i5-i11. PubMed ID: 16120635
    [Abstract] [Full Text] [Related]

  • 17. Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review.
    Sun HY, Singh N.
    Int J Antimicrob Agents; 2010 Mar 01; 35(3):211-8. PubMed ID: 20036518
    [Abstract] [Full Text] [Related]

  • 18. The changing face of epidemiology of invasive fungal disease in Europe.
    Lass-Flörl C.
    Mycoses; 2009 May 01; 52(3):197-205. PubMed ID: 19391253
    [Abstract] [Full Text] [Related]

  • 19. Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies.
    Murali S, Langston A.
    Transpl Infect Dis; 2009 Dec 01; 11(6):480-90. PubMed ID: 19725908
    [Abstract] [Full Text] [Related]

  • 20. [Drug resistance in the treatment of invasive fungal infections].
    Nordøy I, Gaustad P.
    Tidsskr Nor Laegeforen; 2008 Nov 20; 128(22):2607-11. PubMed ID: 19023376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.